{"id":"https://openalex.org/W2084590458","doi":"https://doi.org/10.2147/tcrm.2006.2.4.435","title":"Role of erlotinib in the management of pancreatic cancer","display_name":"Role of erlotinib in the management of pancreatic cancer","publication_year":2006,"publication_date":"2006-12-01","ids":{"openalex":"https://openalex.org/W2084590458","doi":"https://doi.org/10.2147/tcrm.2006.2.4.435","mag":"2084590458","pmid":"https://pubmed.ncbi.nlm.nih.gov/18360654","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1936363"},"language":"en","primary_location":{"id":"doi:10.2147/tcrm.2006.2.4.435","doi":"https://doi.org/10.2147/tcrm.2006.2.4.435","is_oa":true,"landing_page_url":"https://doi.org/10.2147/tcrm.2006.2.4.435","pdf_url":"https://www.dovepress.com/getfile.php?fileID=2713","source":{"id":"https://openalex.org/S204453222","display_name":"Therapeutics and Clinical Risk Management","issn_l":"1176-6336","issn":["1176-6336","1178-203X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutics and Clinical Risk Management","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.dovepress.com/getfile.php?fileID=2713","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004047300","display_name":"Naureen Starling","orcid":"https://orcid.org/0000-0002-1496-6792","observed_orcids":["https://orcid.org/0000-0002-1496-6792"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Naureen Starling","raw_affiliation_strings":["Royal Marsden Hospital, Sutton, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Hospital, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052825850","display_name":"John P. Neoptolemos","orcid":"https://orcid.org/0000-0002-6201-7399","observed_orcids":["https://orcid.org/0000-0002-6201-7399"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]},{"id":"https://openalex.org/I2802775644","display_name":"Royal Liverpool University Hospital","ror":"https://ror.org/01ycr6b80","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802729160","https://openalex.org/I2802775644"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John Neoptolemos","raw_affiliation_strings":["School of Cancer Studies, University of Liverpool, Royal Liverpool University Hospital, Liverpool, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Cancer Studies, University of Liverpool, Royal Liverpool University Hospital, Liverpool, UK","institution_ids":["https://openalex.org/I146655781","https://openalex.org/I2802775644"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056345420","display_name":"David Cunningham","orcid":"https://orcid.org/0000-0001-5158-1069","observed_orcids":["https://orcid.org/0000-0001-5158-1069"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Cunningham","raw_affiliation_strings":["Gastrointestinal and Lymphoma Units, Royal Marsden Hospital, Sutton, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gastrointestinal and Lymphoma Units, Royal Marsden Hospital, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I4210121186"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":null,"fwci":0.3741,"has_fulltext":true,"cited_by_count":29,"citation_normalized_percentile":{"value":0.66795194,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"2","issue":"4","first_page":"435","last_page":"445"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10760","display_name":"Pancreatitis Pathology and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":1.0},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9860000014305115},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.8690000176429749},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6460000276565552},{"id":"https://openalex.org/keywords/metastatic-pancreatic-cancer","display_name":"metastatic pancreatic cancer","score":0.859000027179718},{"id":"https://openalex.org/keywords/locally-advanced-pancreatic-cancer","display_name":"locally advanced pancreatic cancer","score":0.9369999766349792},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.75},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.4779999852180481},{"id":"https://openalex.org/keywords/patient-selection","display_name":"patient selection","score":0.5690000057220459},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.5249999761581421}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9470825791358948},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.916675865650177},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.6549490690231323},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43032991886138916},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3861490786075592},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3853471279144287},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35195836424827576},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.0835002064704895}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.2147/tcrm.2006.2.4.435","doi":"https://doi.org/10.2147/tcrm.2006.2.4.435","is_oa":true,"landing_page_url":"https://doi.org/10.2147/tcrm.2006.2.4.435","pdf_url":"https://www.dovepress.com/getfile.php?fileID=2713","source":{"id":"https://openalex.org/S204453222","display_name":"Therapeutics and Clinical Risk Management","issn_l":"1176-6336","issn":["1176-6336","1178-203X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutics and Clinical Risk Management","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:1825391","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1936363","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:1936363","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1936363","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ther Clin Risk Manag","raw_type":"Text"},{"id":"pmid:18360654","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18360654","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutics and clinical risk management","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.279.3122","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.279.3122","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/37/f7/Ther_Clin_Risk_Manag_2006_Dec_2(4)_435-445.tar.gz","raw_type":"text"}],"best_oa_location":{"id":"doi:10.2147/tcrm.2006.2.4.435","doi":"https://doi.org/10.2147/tcrm.2006.2.4.435","is_oa":true,"landing_page_url":"https://doi.org/10.2147/tcrm.2006.2.4.435","pdf_url":"https://www.dovepress.com/getfile.php?fileID=2713","source":{"id":"https://openalex.org/S204453222","display_name":"Therapeutics and Clinical Risk Management","issn_l":"1176-6336","issn":["1176-6336","1178-203X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutics and Clinical Risk Management","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2084590458.pdf","grobid_xml":"https://content.openalex.org/works/W2084590458.grobid-xml"},"referenced_works_count":72,"referenced_works":["https://openalex.org/W30384279","https://openalex.org/W1495214474","https://openalex.org/W1525495286","https://openalex.org/W1627039822","https://openalex.org/W1659692600","https://openalex.org/W1779286308","https://openalex.org/W1854099548","https://openalex.org/W1931508686","https://openalex.org/W1931708823","https://openalex.org/W1964321121","https://openalex.org/W1964717481","https://openalex.org/W1968151389","https://openalex.org/W1978500759","https://openalex.org/W1985101923","https://openalex.org/W1985466280","https://openalex.org/W1997136340","https://openalex.org/W2004869577","https://openalex.org/W2008803651","https://openalex.org/W2012976896","https://openalex.org/W2018687969","https://openalex.org/W2022066131","https://openalex.org/W2024870616","https://openalex.org/W2030229250","https://openalex.org/W2039633811","https://openalex.org/W2043696829","https://openalex.org/W2050818286","https://openalex.org/W2058620780","https://openalex.org/W2068480412","https://openalex.org/W2074763653","https://openalex.org/W2080267208","https://openalex.org/W2083452953","https://openalex.org/W2097642908","https://openalex.org/W2103134643","https://openalex.org/W2109823193","https://openalex.org/W2114291028","https://openalex.org/W2116150263","https://openalex.org/W2117105709","https://openalex.org/W2118986158","https://openalex.org/W2121120744","https://openalex.org/W2123413031","https://openalex.org/W2129056290","https://openalex.org/W2130616229","https://openalex.org/W2131361386","https://openalex.org/W2134610254","https://openalex.org/W2135836172","https://openalex.org/W2142850084","https://openalex.org/W2148054025","https://openalex.org/W2152105216","https://openalex.org/W2154574630","https://openalex.org/W2155152706","https://openalex.org/W2155977433","https://openalex.org/W2156394877","https://openalex.org/W2157942157","https://openalex.org/W2158134441","https://openalex.org/W2159506251","https://openalex.org/W2160970947","https://openalex.org/W2162651519","https://openalex.org/W2162724777","https://openalex.org/W2163402367","https://openalex.org/W2163592822","https://openalex.org/W2166994863","https://openalex.org/W2170655985","https://openalex.org/W2181371279","https://openalex.org/W2242848604","https://openalex.org/W2244318296","https://openalex.org/W2246417197","https://openalex.org/W2272276923","https://openalex.org/W2278057905","https://openalex.org/W2284392711","https://openalex.org/W2592830569","https://openalex.org/W4250341452","https://openalex.org/W4252139475"],"related_works":["https://openalex.org/W7099384406","https://openalex.org/W2163866397","https://openalex.org/W2168849655","https://openalex.org/W2421782557","https://openalex.org/W2065093995","https://openalex.org/W4250341452","https://openalex.org/W2195486401","https://openalex.org/W4387722558","https://openalex.org/W2158134441","https://openalex.org/W2042015713"],"abstract_inverted_index":{"Pancreatic":[0],"cancer":[1,108,124,154],"is":[2,70],"a":[3,8,18,40,64,71,127],"largely":[4],"chemo-resistant":[5],"disease":[6],"with":[7,52,61,111,150,161],"poor":[9],"prognosis.":[10],"Despite":[11],"the":[12,43,88,131,143,169],"adoption":[13],"of":[14,20,35,42,57,91,133,146,171],"gemcitabine":[15,62,134,138,151],"monotherapy":[16],"as":[17],"standard":[19],"care,":[21],"outcomes":[22],"remain":[23],"poor.":[24],"Until":[25],"recently":[26],"randomized":[27,114,158],"phase":[28,115],"III":[29,116],"studies":[30],"have":[31],"not":[32],"demonstrated":[33],"superiority":[34],"various":[36],"cytotoxic":[37],"combinations":[38],"or":[39],"number":[41],"newer":[44],"biologic":[45],"targeted":[46],"drugs.":[47],"The":[48,140],"situation":[49],"has":[50,83,102,125],"changed":[51],"capecitabine":[53],"and":[54,97,121,164],"erlotinib,":[55],"either":[56],"which":[58,82],"in":[59,67,87,109,118,148,152,156],"combination":[60,110,132,149],"produces":[63],"small":[65,72],"increase":[66],"survival.":[68],"Erlotinib":[69],"molecule":[73],"tyrosine":[74],"kinase":[75],"inhibitor":[76],"against":[77,106],"epidermal":[78],"growth":[79],"factor":[80],"receptor":[81],"an":[84],"important":[85],"role":[86],"molecular":[89],"pathogenesis":[90],"pancreatic":[92,107,123,153],"cancer.":[93],"In":[94],"both":[95],"pre-clinical":[96],"early":[98],"clinical":[99,144],"evaluation":[100],"it":[101],"shown":[103,126],"anti-tumor":[104],"activity":[105],"gemcitabine.":[112],"A":[113],"study":[117],"locally":[119],"advanced":[120],"metastatic":[122],"survival":[128],"advantage":[129],"for":[130,142],"plus":[135],"erlotinib":[136,147],"over":[137],"alone.":[139],"rationale":[141],"development":[145],"culminating":[155],"this":[157,172],"trial,":[159],"together":[160],"pharmacologic,":[162],"toxicity":[163],"patient":[165],"selection":[166],"considerations":[167],"form":[168],"focus":[170],"review.":[173]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}